PROTECH BRONCHI-SHIELD I BORDETELLA BRONCHISEPTICA LIVE VACCINE

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredjent attiv:

BORDETELLA BRONCHISEPTICA

Disponibbli minn:

Boehringer Ingelheim Animal Health Australia Pty. Ltd.

INN (Isem Internazzjonali):

vaccine - canine Bordetella

Għamla farmaċewtika:

MISC. VACCINES OR ANTI SERA

Kompożizzjoni:

BORDETELLA BRONCHISEPTICA VACCINE-MICROBIAL Active 0.0 P

Unitajiet fil-pakkett:

!10 x 1mL; !diluent; !sterile; !vial; #25 x 1mL; #diluent; #sterile; #vial; $10 x 1mL; $dose vial; $single; %10 x 1mL; %intrana-

Klassi:

VM - Veterinary Medicine

Grupp terapewtiku:

DOG - OVER 3 WEEKS

Żona terapewtika:

IMMUNOTHERAPY

Indikazzjonijiet terapewtiċi:

BORDETELLA BRONCHISEPTICA | CANINE COUGH SYNDROME | INFECTIOUS TRACHEOBRONCHITIS

Sommarju tal-prodott:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG - OVER 3 WEEKS: [BORDETELLA BRONCHISEPTICA]; For the active immunisation by intranasal inoculation of healthy dogs over 3 weeks of age as an aid in preventing canine cough caused by Bordetella bronchiseptica.DO NOT ADMINISTER THE VACCINE BY INJECTION- USE ONLY INTRANASALLY WITH THE APPLICATOR SUPPLIED. Vaccinate only healthy dogs, with normal temperatures. Dogs under treatment with immunosuppressive drugs should be vaccinated with caution.

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2023-07-01

Fuljett ta 'informazzjoni

PRESCRIPTION
ANIMAL
REMEDY
KEEP
OUT
OF REACH OF CHILDREN
FOR
ANIMAL
TREATMENT
ONLY
Protech® Bronchi-Shield® I
Bordetella pronchiseptica Vaccine
Contents: 1 dose·
VIAL
LABEL
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
Store between
z•c
-
8•c.
Do not freeze.
Protect from light.
Batch No.:
Expiry Date:
APVMA 51823/55178
Boehringer
lngelheim
+
RLP
Approved
Infopest
Verified
TRAY
LABEL-
PRESCRIPTION ANIMAL REMEDY
KEEP.
OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
PROTECH®
BRONCHI-SHIELD® I
BORDETELLA BRONCHISEPTICA VACCINE
For the active immunisation by intranasal inoculation
of
healthy dogs over 3 weeks
of
age as an
aid
in
preventing canine cough caused by
Bordetella bronchiseptica.
ACTIVE CONSTITUENT
Each dose contains live avirulent
Bordetella bronchiseptica
(2 x 10
6
CFU per dose).
CONTENTS:
10 x 1 dose vials
10 x
1
mL diluent
1
0 x intranasal applicators
(25
x 1 dose vials
•
25 x 1 mL diluent
25 x intranasal applicators)
READ ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
DIRECTIONS FOR USE
Use entire contents reconstituted with sterile water for injection
(1
ml)
and use by intranasal
administration with
syring~
and intranasal applicator.
APVMA No 51823/55178
Store between 2-8•. Do not freeze.
Protect from light.
Batch
No.
Expiry Date:
Boehringer lngelheim Pty Limited
Animal Health Division
78 Waterloo Road
North Ryde
NSW
2113
PACKAGING INSERT
PRESCRIPTION ANIMAL REMEDY
KEEP OUT
OF
REACH
OF
CHILDREN
FOR ANIMAL TREATMENT ONLY
Protech® Bronchi-Shield® I
Bordetella bronchiseptica Vaccine
For
the
active immunisation by intranasal inoculation of healthy dogs over 3
weeks of age
as
an
aid
in
preventing canine cough caused by
Bordetella bronchiseptica.
Composition
.
Each dose contains live avirulent
Bordetella bronchiseptica
(2
x 10
6
CFU
per dose).
DIRECTION FOR USE
Vaccinate only
healthy
dogs,
with
normal temperatures
Dogs
under
treatment
with
immunosuppressive
drugs
should
be vaccinated
with
caution
Dogs
already being given antibacterial agents
with
activity against
B.
bronchiseptica
should

Karatteristiċi tal-prodott

CS: 1.7.2
Page:
1
MATERIAL SAFETY DATA SHEET
4
of
Infosafe No™
LQ087
August 2011
ISSUED by BOEHRING
Issue Date :
PROTECH® BRONCHI-SHIELD I BORDETELLA BRONCHISEPTICA LIVE
VACCINE
Product Name :
Not classified as hazardous
1. IDENTIFICATION OF THE MATERIAL AND SUPPLIER
PROTECH® BRONCHI-SHIELD I BORDETELLA BRONCHISEPTICA LIVE VACCINE
PRODUCT NAME
Boehringer Ingelheim Pty. Limited
COMPANY NAME
78 Waterloo Rd North Ryde
NSW 2113 Australia
ADDRESS
1800 038 037
EMERGENCY TEL.
Tel: [phone]
Fax: [phone]
TELEPHONE/FAX
NUMBER
[e-mail]
EMAIL
For the immunisation by intranasal innoculation of healthy dogs as an
aid in
preventing canine cough caused by Bordetella Bronchiseptica.
RECOMMENDED USE
2. HAZARDS IDENTIFICATION
Not classified as hazardous
NON-HAZARDOUS SUBSTANCE.
NON-DANGEROUS GOODS.
Hazard classification according to the criteria of NOHSC.
Dangerous goods classification according to the Australia Dangerous
Goods
Code.
HAZARD
CLASSIFICATION
3. COMPOSITION/INFORMATION ON INGREDIENTS
NAME
CAS
PROPORTION
INGREDIENTS
Ingredients determined
not to be hazardous
-
Balance
Freeze dried live
avirulent Bordetella
bronchiseptica
-
4. FIRST AID MEASURES
No special precautions required. However, if inhaled, remove affected
person
from contaminated area. Keep at rest until recovered. If symptoms
persist seek
medical attention.
INHALATION
Do not induce vomiting. Wash out mouth thoroughly with water. If
symptoms
develop seek medical attention.
INGESTION
Wash affected area thoroughly with soap and water. If symptoms develop
seek
medical attention.
Self-Injection: Accidental self injection may lead to an inflammatory
response
and medical advice should be sought on the management of deep
injections,
particularly those near a joint or associated with bruising. If
possible the
application of gentle squeezing pressure with absorbent material (e.g.
facial
tissues) at the injection site will swab up unabsorbed vaccine. Strong
squeezing of the site should be avoided. The damaged area should be